| Understanding extracellular vesicle diversity - current status |
25 |
| Red blood cells as an organ? How deep omics characterization of the most abundant cell in the human body highlights other systemic metabolic functions beyond oxygen transport |
18 |
| Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future |
14 |
| The power of proteasome inhibition in multiple myeloma |
13 |
| Challenges and promise at the interface of metaproteomics and genomics: an overview of recent progress in metaproteogenomic data analysis |
12 |
| Paper spray ionization mass spectrometry: recent advances and clinical applications |
12 |
| Microvesicles as promising biological tools for diagnosis and therapy |
11 |
| Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury |
11 |
| The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development |
10 |
| Proteomics analysis to compare the venom composition between Naja naja and Naja kaouthia from the same geographical location of eastern India: Correlation with pathophysiology of envenomation and immunological cross-reactivity towards commercial polyantivenom |
10 |
| Proteomic analysis and antivenomics study of Western India Naja naja venom: correlation between venom composition and clinical manifestations of cobra bite in this region |
10 |
| Applications of MALDI-TOF mass spectrometry in clinical proteomics |
9 |
| Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives |
9 |
| Nanoproteomics comes of age |
9 |
| Application of the MALDI Biotyper to clinical microbiology: progress and potential |
9 |
| MAPPs for the identification of immunogenic hotspots of biotherapeutics; an overview of the technology and its application to the biopharmaceutical arena |
9 |
| Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry |
9 |
| Proteomic analysis reveals geographic variation in venom composition of Russell's Viper in the Indian subcontinent: implications for clinical manifestations post-envenomation and antivenom treatment |
9 |
| Deepening our understanding of HDL proteome |
8 |
| Snake venomics - from low-resolution toxin-pattern recognition to toxin-resolved venom proteomes with absolute quantification |
8 |
| The role of mass spectrometry in the characterization of biologic protein products |
8 |
| Cell-surface proteomics for the identification of novel therapeutic targets in cancer |
8 |
| Quantitative proteomic analysis of venom from Southern India common krait (Bungarus caeruleus) and identification of poorly immunogenic toxins by immune-profiling against commercial antivenom |
8 |
| Protein biomarkers for subtyping breast cancer and implications for future research |
8 |
| Foodomics for human health: current status and perspectives |
7 |
| Advances in understanding the role of angiotensin-regulated proteins in kidney diseases |
7 |
| Post-translational and transcriptional dynamics - regulating extracellular vesicle biology |
7 |
| Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions? |
7 |
| Identification and characterization of protein cross-links induced by oxidative reactions |
7 |
| Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers |
7 |
| An update on the routine application of MALDI-TOF MS in clinical microbiology |
7 |
| Understanding Leishmania parasites through proteomics and implications for the clinic |
7 |
| Characterizing disease-associated changes in post-translational modifications by mass spectrometry |
6 |
| Proteomics and pulse azidohomoalanine labeling of newly synthesized proteins: what are the potential applications? |
6 |
| Proteomic serum biomarkers for neuromuscular diseases |
6 |
| Irreversible oxidative post-translational modifications in heart disease |
6 |
| Interactomics and tick vaccine development: new directions for the control of tick-borne diseases |
5 |
| Exposure to tobacco smoke and low birth weight: from epidemiology to metabolomics |
5 |
| Employing proteomics in the study of antigen presentation: an update |
5 |
| Advances in cell-free protein array methods |
5 |
| Peptidomic analysis in the discovery of therapeutically valuable peptides in amphibian skin secretions |
5 |
| Cancer biomarker discovery and translation: proteomics and beyond |
5 |
| Current trends in protein acetylation analysis |
5 |
| Clinical insights gained through metabolomic analysis of human breast milk |
5 |
| Proteomic analysis of synovial fluid: current and potential uses to improve clinical outcomes |
5 |
| Platelet proteomics: from discovery to diagnosis |
5 |
| Proteomics and the microbiome: pitfalls and potential |
5 |
| Sarcoidosis: proteomics and new perspectives for improving personalized medicine |
4 |
| Does the dysregulation of matrix metalloproteinases contribute to recurrent implantation failure? |
4 |
| Understanding the role of chondrocytes in osteoarthritis: utilizing proteomics |
4 |
